Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit

Alcohol

Volumn 44, Issue 7-8, 2010, Pages 629-634

  Goh, Y Ingrid ^a,b   Hutson, Janine R ^a,c   Lum, Lisa ^d   Roukema, Henry ^d   Gareri, Joey ^a,b   Lynn, Hazel ^e   Koren, Gideon ^a,b,c,f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Grey Bruce Health Unit ^*  (Canada)

^e Grey Bruce Health Unit   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Fatty acid ethyl esters; Fetal alcohol spectrum disorder; High risk; Meconium; Pregnancy; Prevalence; Screening

Indexed keywords

FATTY ACID ESTER; OLEIC ACID ETHYL ESTER;

ALCOHOL CONSUMPTION; ARTICLE; CANADA; CONTROLLED STUDY; FATTY ACID ANALYSIS; FEMALE; FETAL ALCOHOL SYNDROME; FETUS OUTCOME; GAS CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; MASS SPECTROMETRY; MECONIUM; NEWBORN; PRENATAL EXPOSURE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; TERTIARY HEALTH CARE;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; ETHANOL; FATTY ACIDS; FEMALE; FETAL ALCOHOL SYNDROME; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MECONIUM; OLEIC ACIDS; PREGNANCY; PREGNANCY, HIGH-RISK;

EID: 78649629523     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2010.02.008     Document Type: Article

References (26)

1. Bearer C.F., Jacobson J.L., Jacobson S.W., Barr D., Croxford J., Molteno C.D., et al. Validation of a new biomarker of fetal exposure to alcohol. J. Pediatr. 2003, 143:463-469.
2. Bearer C.F., Santiago L.M., O'Riordan M.A., Buck K., Lee S.C., Singer L.T. Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J. Pediatr. 2005, 146:824-830.
3. Centers for Disease Control and Prevention Alcohol consumption among women who are pregnant or who might become pregnant-United States, 2002. MMWR Morb. Mortal. Wkly. Rep. 2004, 53:1178-1181.
4. Chan D., Bar-Oz B., Pellerin B., Paciorek C., Klein J., Kapur B., et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther. Drug Monit. 2003, 25:271-278.
5. Chan D., Caprara D., Blanchette P., Klein J., Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin. Biochem. 2004, 37:429-438.
6. Chan D., Knie B., Boskovic R., Koren G. Placental handling of fatty acid ethyl esters: perfusion and subcellular studies. J. Pharmacol. Exp. Ther. 2004, 310:75-82.
7. Gareri J., Lynn H., Handley M., Rao C., Koren G. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Ther. Drug Monit. 2008, 30:239-245.
8. Hutson J.R., Aleksa K., Pragst F., Koren G. Detection and quantification of fatty acid ethyl esters in meconium by headspace-solid-phase microextraction and gas chromatography-mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2009, 877:8-12.
9. Koren G., Nulman I., Chudley A.E., Loocke C. Fetal alcohol spectrum disorder. CMAJ 2003, 169:1181-1185.
10. Lupton C., Burd L., Harwood R. Cost of fetal alcohol spectrum disorders. Am. J. Med. Genet. C. Semin. Med. Genet. 2004, 127C:42-50.
11. Mojtabai R., Singh P. Implications of co-occurring alcohol abuse for role impairment, health problems, treatment seeking, and early course of alcohol dependence. Am. J. Addict. 2007, 16:300-309.
12. Moore C., Jones J., Lewis D., Buchi K. Prevalence of fatty acid ethyl esters in meconium specimens. Clin. Chem. 2003, 49:133-136.
13. National Institute of Child Health and Human Development. High Risk Pregnancy. 12-4-2006. Accessed May 10, 2010. http://www.nic.hd.nih.gov/health/topics/high_risk_pregnancy.cfm.
14. Noland J.S., Singer L.T., Arendt R.E., Minnes S., Short E.J., Bearer C.F. Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana. Alcohol. Clin. Exp. Res. 2003, 27:647-656.
15. Ostrea E.M., Hernandez J.D., Bielawski D.M., Kan J.M., Leonardo G.M., Abela M.B., et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect?. Alcohol. Clin. Exp. Res. 2006, 30:1152-1159.
16. Peterson J., Kirchner H.L., Xue W., Minnes S., Singer L.T., Bearer C.F. Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age. J. Pediatr. 2008, 152:788-792.
17. Pragst F., Auwaerter V., Sporkert F., Spiegel K. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci. Int. 2001, 121:76-88.
18. Sampson P.D., Streissguth A.P., Bookstein F.L., Little R.E., Clarren S.K., Dehaene P., et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology 1997, 56:317-326.
19. Sarkar M., Burnett M., Carriere S., Cox L.V., Dell C.A., Gammon H., et al. Screening and recording of alcohol use among women of child-bearing age and pregnant women. Can. J. Clin. Pharmacol. 2009, 16:e242-e263.
20. Stade B., Ungar W.J., Stevens B., Beyen J., Koren G. Cost of fetal alcohol spectrum disorder in Canada. Can. Fam. Physician 2007, 53:1303-1304.
21. Stark K.D., Beblo S., Murthy M., Buda-Abela M., Janisse J., Rockett H., et al. Comparison of bloodstream fatty acid composition from African-American women at gestation, delivery, and postpartum. J. Lipid Res. 2005, 46:516-525.
22. Stark K.D., Beblo S., Murthy M., Whitty J.E., Buda-Abela M., Janisse J., et al. Alcohol consumption in pregnant, black women is associated with decreased plasma and erythrocyte docosahexaenoic acid. Alcohol. Clin. Exp. Res. 2005, 29:130-140.
23. Stoler J.M., Huntington K.S., Peterson C.M., Peterson K.P., Daniel P., Aboagye K.K., et al. The prenatal detection of significant alcohol exposure with maternal blood markers. J. Pediatr. 1998, 133:346-352.
24. Streissguth A.P., Bookstein F.L., Barr H.M., Sampson P.D., O'Malley K., Young J.K. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J. Dev. Behav. Pediatr. 2004, 25:228-238.
25. Waisbren S.E., Doherty L.B., Bailey I.V., Rohr F.J., Levy H.L. The New England Maternal PKU Project: identification of at-risk women. Am. J. Public Health 1988, 78:789-792.
26. Zaffanello M., Maffeis C., Zamboni G. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes. J. Perinat. Med. 2005, 33:246-251.